Document is current
Any future updates will be listed below
-
Authors
Castori, Marco https://orcid.org/0000-0003-3604-194X
Mastroianno, Sandra
Fontana, Andrea
Morlino, Silvia https://orcid.org/0000-0002-1094-1774
Nardella, Grazia
Di Muro, Ester
Palumbo, Pietro
Leone, Maria Pia
Pracella, Riccardo
Palumbo, Orazio https://orcid.org/0000-0001-6583-3482
Petracca, Antonio
Potenza, Domenico Rosario
Carella, Massimo
De Luca, Giovanni
Coli, Carlo
Massaro, Raimondo Salvatore
De Santis, Rosa
Vaccaro, Lorenzo https://orcid.org/0000-0002-8233-3241
Cesana, Marcella
Cacchiarelli, Davide https://orcid.org/0000-0002-9621-6716
Copetti, Massimiliano
Fusco, Carmela
Di Stolfo, Giuseppe
-
Funding
Funding for this research was provided by:
Ministry of Health, Italy | Agenzia Italiana del Farmaco, Ministero della Salute (Ricerca Corrente 2022-2024, PNRR-MCNT2-2023-12377305 “EUCARDIS”, Piano Operativo Salute Traiettoria 3, Genomed”; Ricerca Finalizzata 2021)
Fondazione Telethon (grant agreement 759154, CellKarma)
- License Information
-
More Information
Article History
Received: 10 October 2024
Revised: 28 March 2025
Accepted: 18 April 2025
First Online: 30 April 2025
Competing interests
: Davide Cacchiarelli is founder, shareholder, and consultant of NEGEDIA S.r.l. All the other authors declare that there is no conflict of interest concerning this work.
: This study is in accordance with the 1984 Helsinki declaration and subsequent revisions, and received IRB approval by the local ethics committee ‘Azienda Ospedaliero Universitaria Policlinico Foggia’ (approval no. 89/CE/2024).
: Informed consent was obtained from all individual participants included in the study.
